Every open market buy and sale of Acadia Pharmaceuticals Inc stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $2.5M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when ACAD insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an ACAD officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every ACAD insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Oct 30, 2026 | Mark C. SchneyerEvp, CFO | Sale | 3,321 | $20.88 | $69K | 71,322 | Oct 30Form 4 |
| Aug 6, 2026 | Mark C. SchneyerEvp, CFO | Sale plan | 20,141 | $29.16 | $587K | 67,828 | Aug 7Form 4 |
| Jul 30, 2026 | Elizabeth H.Z. ThompsonEVP, Head of Research & Dev | Sale | 16,558 | $26.13 | $433K | 18,994 | Jul 31Form 4 |
| Jun 26, 2026 | James KiharaPrincipal Accounting Officer | Sale plan | 11,421 | $26.08 | $298K | 13,088 | Jun 29Form 4 |
| May 26, 2026 | James KiharaPrincipal Accounting Officer | Sale | 5,401 | $21.18 | $114K | 24,509 | May 27Form 4 |
| May 4, 2026 | James KiharaPrincipal Accounting Officer | Sale | 1,332 | $21.79 | $29K | 29,129 | May 5Form 4 |
| May 4, 2026 | Mark C. SchneyerEvp, CFO | Sale | 3,506 | $21.79 | $76K | 66,145 | May 5Form 4 |
| Apr 7, 2026 | James KiharaPrincipal Accounting Officer | Sale | 1,030 | $22.20 | $23K | 27,865 | Apr 7Form 4 |
| Apr 7, 2026 | Mark C. SchneyerEvp, CFO | Sale | 2,709 | $22.20 | $60K | 62,836 | Apr 7Form 4 |
| Mar 26, 2026 | James KiharaPrincipal Accounting Officer | Sale | 1,942 | $21.57 | $42K | 26,885 | Mar 26Form 4 |
| Mar 26, 2026 | Mark C. SchneyerEvp, CFO | Sale | 7,385 | $21.55 | $159K | 60,269 | Mar 26Form 4 |
| Mar 25, 2026 | Jennifer J RhodesEvp, Chief Legal Officer, Sec | Sale | 3,844 | $21.47 | $83K | 11,280 | Mar 26Form 4 |
| Mar 25, 2026 | Adams Catherine OwenCEO | Sale | 11,641 | $21.47 | $250K | 14,803 | Mar 26Form 4 |
| Mar 25, 2026 | Elizabeth H.Z. ThompsonEVP, Head of Research & Dev | Sale | 3,435 | $21.47 | $74K | 3,280 | Mar 26Form 4 |
| Feb 9, 2026 | Jennifer J RhodesEvp, Chief Legal Officer, Sec | Sale | 6,950 | $23.38 | $162K | 7,609 | Feb 10Form 4 |
ACAD insider trading FAQ
Are ACAD insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of ACAD on the open market in 0 trades, and 5 sold $2.5M in 15 trades, 36% of that under pre-arranged trading plans.
When did an ACAD insider last buy shares?
There has been no open market insider purchase of ACAD in the last two years.
When did an ACAD insider last sell shares?
Mark C. Schneyer (Evp, CFO) sold 3,321 shares for $69K on Oct 30, 2026.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
